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ertebrate muscle spindle stretch receptors are im-
portant for limb position sensation (propriocep-
tion) and stretch reﬂexes. The structurally complex
stretch receptor arises from a single myotube, which is
transformed into multiple intrafusal muscle ﬁbers by sen-
sory axon–dependent signal transduction that alters gene
expression in the contacted myotubes. The sensory-derived
signal transduction pathways that specify the fate of myo-
tubes are very poorly understood. The zinc ﬁnger tran-
scription factor, 
 
early growth response gene 3
 
 (
 
Egr3
 
), is
selectively expressed in sensory axon–contacted myotubes,
and it is required for normal intrafusal muscle ﬁber differ-
entiation and spindle development. Here, we show that
overexpression of 
 
Egr3
 
 in primary myotubes in vitro leads
V
 
to the expression of a particular repertoire of genes, some
of which we demonstrate are also regulated by Egr3 in de-
veloping intrafusal muscle ﬁbers within spindles. Thus, our
results identify a network of genes that are regulated by
Egr3 and are involved in intrafusal muscle ﬁber differenti-
ation. Moreover, we show that Egr3 mediates myotube
fate speciﬁcation that is induced by sensory innervation
because skeletal myotubes that express Egr3 independent
of other sensory axon regulation are transformed into
muscle ﬁbers with structural and molecular similarities to
intrafusal muscle ﬁbers. Hence, 
 
Egr3
 
 is a target gene that
is regulated by sensory innervation and that mediates
gene expression involved in myotube fate speciﬁcation
and intrafusal muscle ﬁber morphogenesis.
 
Introduction
 
Muscle spindles are stretch receptors that mediate myotactic
stretch reflexes as well as limb and axial body position sensa-
tion (proprioception) in vertebrates. They consist of specialized,
encapsulated muscle fibers (intrafusal muscle fibers) that are in-
nervated by sensory (groups Ia and II) and motor (fusimotor)
axons to form mechanoreceptors that relay skeletal muscle
stretch sensation to the central nervous system. Late prenatal or
early postnatal sensory denervation, but not motor denervation,
of developing skeletal muscles leads to spindle degeneration,
which indicates that normal spindle development is dependent
on sensory, but not fusimotor, innervation (Zelená, 1957; Ze-
lená and Soukup, 1973; Kucera and Walro, 1992). Spindle
morphogenesis requires intact sensory innervation, and this
has been convincingly demonstrated in mice that lack either
neurotrophin-3 (NT-3) or its cognate, tyrosine kinase receptor/
TrkC (Ernfors et al., 1994; Klein et al., 1994; Tessarollo et al.,
1994). Proprioceptive sensory neuron survival during develop-
ment depends on NT-3–tyrosine kinase receptor C signaling,
and when it is abrogated in mutant mice Ia-afferents do not form
properly to induce spindle morphogenesis in the periphery. Thus,
Ia-afferent–derived signaling has been recognized as an essential
aspect of muscle spindle induction for several decades, but not
until recently have some specific signaling mediators been iden-
tified. For example, neuregulin-1 (Nrg1) appears to be an essen-
tial Ia-afferent–derived mediator of spindle morphogenesis, and
although Ia-afferents establish contact with myotubes, muscle
spindle morphogenesis and some intrafusal muscle fiber–spe-
cific genes are not appropriately induced in mice when sensory
neurons are deficient in 
 
Nrg1
 
 (Hippenmeyer et al., 2002). Simi-
larly, muscle spindle morphogenesis is impaired in mice with a
muscle-specific deficiency of erythroblastic leukemia viral onco-
gene homologue 2
 
 
 
(ErbB2), an essential component of the Nrg1
tyrosine kinase receptor signaling complex (Andrechek et al.,
2002; Leu et al., 2003). Together, these results indicate that
Ia-afferents induce spindle morphogenesis by releasing Nrg1 to
engage ErbB2-dependent signal transduction in a subpopulation
of myotubes that receive sensory myoneural contacts.
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Comparatively little is known about the gene regulatory
networks that are engaged by ErbB2 signaling in Ia-afferent–
contacted myotubes in order to induce their transformation to in-
trafusal muscle fibers. Presumably, de novo gene expression is
required after sensory myoneural contact is established to spec-
ify the fate of myotubes that will become morphologically and
biochemically distinct intrafusal muscle fibers; to mediate termi-
nal Schwann cell differentiation that will generate the fusiform
spindle capsule; and to regulate growth factors that are induced
to establish and/or maintain specialized, spindle-related sensory
and motor innervation. Accordingly, several transcriptional reg-
ulators are induced in myotubes shortly after they are contacted
by Ia-afferents, including some Ets-related transcription factors,
 
ER81
 
 (Arber et al., 2000), Pea3 (Livet et al., 2002), 
 
Ets-related
protein
 
 
 
(
 
ERM
 
; Hippenmeyer et al., 2002), and the zinc finger
transcription factor 
 
early growth response gene 3
 
 (
 
Egr3
 
; Tour-
tellotte and Milbrandt, 1998). They are all regulated by Ia-affer-
ent–derived Nrg1 after myotube contact (Hippenmeyer et al.,
2002), indicating that they are candidate transcription factors
that are involved in ErbB2-dependent and myotube-intrinsic
gene expression related to spindle morphogenesis. However,
whether Ets-related transcription factors regulate gene expres-
sion that is required for spindle morphogenesis has been difficult
to discern. For example, ER81 is expressed in developing spin-
dles, proprioceptive sensory neurons, and motor neurons. In
 
ER81
 
-deficient mice, the spindle number is altered in some mus-
cles because ER81 has a role in the specification of some propri-
oceptive neurons (Kucera et al., 2002). In contrast, muscle spin-
dles show no obvious defects in 
 
Pea3
 
-deficient mice, despite the
fact that it is also coordinately expressed by intrafusal muscle fi-
bers, motor neurons, and sensory neurons (Livet et al., 2002). Fi-
nally, ERM expression is not restricted to spindles in the devel-
oping muscle, and its role in muscle spindle morphogenesis has
not been studied because 
 
ERM
 
-deficient mice die before muscle
spindle induction (Hippenmeyer et al., 2002).
Egr3 is a particularly interesting candidate effector mole-
cule of Nrg1–ErbB2 signaling in myotubes. Egr3 is induced in
Ia-afferent–contacted myotubes at a developmental time point
that coincides with Ia-afferent innervation, and it is not ex-
pressed by sensory or motor neurons that innervate them. More-
over, Ia-afferent–contacted myotubes in 
 
Egr3
 
-deficient mice fail
to differentiate into intrafusal muscle fibers that express an
intrafusal muscle fiber–specific, slow developmental myosin
heavy chain (Sd-MyHC; Tourtellotte and Milbrandt, 1998;
Tourtellotte et al., 2001), suggesting that their differentiation
may be impaired. As one of the earliest recognized transcrip-
tional regulators that are induced selectively in myotubes by Ia-
afferent innervation, Egr3 may mediate some aspects of Nrg1–
ErbB2 signaling that is relevant to myotube fate specification
and intrafusal fiber differentiation. However, neither the target
genes regulated by Egr3 in Ia-afferent–contacted myotubes nor
its potential role in myotube fate specification have ever been di-
rectly examined. In this study, we identified many target genes
that are regulated by Egr3 in primary myotubes in vitro and
demonstrated that some of these genes are regulated by Egr3 in
developing spindles in vivo. To examine whether Egr3 has any
instructive role in specifying the fate of myotubes to become
intrafusal muscle fibers, transgenic mice were generated to
express Egr3 in all myotubes independent of Ia-afferent–Nrg1
signaling. These mice were not viable because their skeletal mus-
cle fibers were entirely transformed to contain muscle fibers that
were structurally and biochemically similar to intrafusal muscle
fibers. Considered together, these results demonstrate that Ia-
afferent–Nrg1 signaling in myotubes serves, at least in part, to
regulate 
 
Egr3
 
 as an important transcriptional regulator of myotube
fate specification and intrafusal muscle fiber morphogenesis.
 
Results
 
Egr3-mediated gene regulation in primary 
murine myotubes
 
Egr3 expression is regulated in myotubes by sensory innerva-
tion and Nrg1 signaling in vivo (Tourtellotte et al., 2001; Hippen-
meyer et al., 2002; Jacobson et al., 2004). Ia-afferents contact
myotubes in 
 
Egr3
 
-deficient mice; in the absence of 
 
Egr3
 
-
mediated gene regulation, they do not properly differentiate into
spindles, which leaves the mice with profound sensory ataxia
and proprioceptive deficits (Tourtellotte and Milbrandt, 1998).
To identify target genes that are potentially regulated by Egr3 in
Ia-afferent–contacted myotubes, primary myoblasts were iso-
lated from newborn, wild-type mice and were differentiated into
multinucleated myotubes. One population of myotubes was in-
fected with an adenovirus that coexpressed enhanced GFP
(EGFP) and full-length, transcriptionally active wild-type Egr3
(Egr3
 
WT
 
), whereas another population of myotubes was infected
with an adenovirus that coexpressed EGFP and transcriptionally
inactive truncated Egr3 (Egr3
 
Tr
 
; Fig. 1 A). Primary myotubes
that were infected with 100% efficiency expressed high levels
of transgenic protein and showed no evidence of toxicity (Fig. 1
B). Endogenous Egr3 was not detected in cultured myotubes,
similar to myotubes that neither receive Ia-afferent innervation
nor become intrafusal muscle fibers in vivo (Fig. 1 B, bottom
right; Tourtellotte and Milbrandt, 1998). To identify genes regu-
lated by Egr3 in this primary myotube–cellular context, gene
expression in the adenovirus-infected myotubes was compared
using Affymetrix microarray analysis. The experiment was re-
peated twice, and a four-way analysis of the gene expression
datasets identified 83 unique genes that were up-regulated and
five unique genes that were down-regulated by Egr3
 
WT
 
 in pri-
mary myotubes. Egr3 appears to be a transcriptional activator in
the cellular contexts where it has been studied, which is consis-
tent with the observation that many more genes were up-regu-
lated by Egr3
 
WT
 
 (Table I, 83 genes, 2–244-fold) than were
down-regulated (Table II, five genes, two- to threefold). Al-
though most of the 83 genes identified have not been evaluated
further, up-regulation was confirmed in 15/15 genes examined
by using a real-time PCR analysis on cDNA samples that were
prepared from independently infected primary myotubes (Fig.
1 D, results from 12 genes shown; Table I).
 
Egr3-mediated gene regulation in 
developing muscle spindles
 
To examine whether Egr3 target genes identified in vitro may
also be regulated by Egr3 in a similar cellular context in devel- 
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oping muscle spindles in vivo, we used in situ hybridization to
characterize gene expression patterns in embryonic wild-type
mouse muscles. Egr3 and Pea3 are transcription factors regu-
lated by Ia-afferent–Nrg1 signaling in myotubes, and Ia-affer-
ents contact myotubes in both 
 
Egr3
 
-deficient and 
 
Pea3
 
-defi-
cient mice (Tourtellotte and Milbrandt, 1998; Livet et al., 2002).
Pea3 is not necessary for spindle morphogenesis, but it is a use-
ful marker for localizing Ia-afferent–contacted myotubes in the
developing skeletal muscle (Hippenmeyer et al., 2002). We
found that Pea3 was not regulated by Egr3 because Pea3 expres-
sion was identified in discretely labeled myotubes in 
 
Egr3
 
-defi-
cient mice (Hippenmeyer et al., 2002). However, Pea3-express-
ing myotubes were reduced by 
 
 
 
66% in Egr3-deficient muscles
at the embryonic gestational day (E) 16.5 (Fig. 2 A) and were
reduced by 
 
 
 
86% at E18.5 (Fig. 2 B). Because Pea3 is a marker
of Ia-afferent–myotube contact, the decreased number of Pea3-
expressing myotubes in 
 
Egr3
 
-deficient mice is consistent with
previous observations that demonstrate initial Ia-afferent con-
tact of myotubes, progressive loss of afferents during prenatal
development, and complete loss of afferents in adult 
 
Egr3
 
-defi-
cient mice (Tourtellotte and Milbrandt, 1998; Tourtellotte et al.,
2001). Because some Ia-afferent–contacted, Pea3-expressing
myotubes were present in prenatal 
 
Egr3
 
-deficient muscles, it
was possible to examine potential Egr3 target gene expression
within them. Accordingly, Egr3-dependent gene expression in
skeletal muscle should be restricted to Ia-afferent–contacted
myotubes where Egr3 expression is restricted, and it should be
abrogated in Pea3-expressing (Ia-afferent contacted), 
 
Egr3
 
-defi-
cient myotubes. We examined six target genes that were identi-
fied by Affymetrix microarray analysis (and were confirmed to
be up-regulated in myotubes by real-time PCR analysis) using
in situ hybridization on the muscle. Although three genes (
 
rho-
philin 2 
 
[
 
Rhpn2
 
]; 
 
g-coupled protein receptor 50
 
 [
 
GPR50
 
];
and 
 
activity-regulated cytoskeletal-associated protein
 
 [
 
Arc
 
])
showed no specific localization to muscle spindles (unpublished
data), the three other genes, including two growth factor recep-
tors (
 
low affinity nerve growth factor receptor
 
 [
 
NGFR (p75)
 
];
and 
 
somatostatin receptor type 2
 
 [
 
SSTr2
 
]) and the type III inter-
mediate filament 
 
peripherin 1
 
 (
 
Prph1
 
), appeared to be ex-
pressed selectively by spindles. In E18.5 wild-type skeletal
muscle, NGFR (p75) (Fig. 3 A), SSTr2 (Fig. 3 B), and Prph1
(Fig. 3 C) expression was restricted to muscle spindles similar
to the expression pattern of Egr3. In skeletal muscles from
E18.5 
 
Egr3
 
-deficient mice, NGFR (p75), SSTr2, and Prph1
were not expressed in Pea3-expressing myotubes (Fig. 3, A–C,
bottom). Hence, NGFR (p75), SSTr2, and Prph1 represent new
Figure 1. Identification of Egr3 target genes in primary
murine myotubes. (A) Adenoviruses were generated to
express either EGFP alone (EGFP), full-length, transcrip-
tionally active Egr3 and EGFP (Egr3WT), or transcriptionally
inactive Egr3 and EGFP (Egr3Tr). The transcriptional activity
of the recombinant proteins that were produced by the
viruses was assessed by the early growth response ele-
ment (ERE) luciferase reporter assay. Compared with
EGFP and Egr3Tr-infected myoblasts, Egr3WT infection
showed marked transcriptional activation of the ERE–
luciferase reporter plasmid (mean and standard deviation
shown from two independent transfection-infection experi-
ments, each performed in triplicate). (B) Myotubes were
differentiated for 10 d and infected with either the Egr3WT
or Egr3Tr adenovirus. EGFP fluorescence confirmed 100%
infection efficiency, and immunohistochemistry using a
COOH-terminal Egr3 antibody demonstrated high levels
of nuclear localized Egr3 in Egr3WT-infected myotubes
and no staining in the Egr3Tr-infected myotubes. Results
from the Egr3Tr-infected cells further demonstrated the
lack of endogenous Egr3 expression in wild-type myo-
tubes. Bar, 40  m. (C) Total RNA was extracted from the
myotubes 18 h after infection, and Affymetrix microarray
analysis was performed. The infection experiments were
performed twice, and the gene expression datasets were
compared in a four-way analysis. 83 genes were identi-
fied as up-regulated in all of the single, four-way compar-
isons from 45,200 genes and transcripts that were ana-
lyzed. (D) All of the genes tested (15/15) were confirmed
to represent up-regulated genes by real-time PCR (mean
and standard deviation from four independent infection
experiments and real-time PCR assays, each performed in
triplicate, P   0.05 for all genes). 
JCB • VOLUME 169 • NUMBER 2 • 2005 260
 
Table I. 
 
Up-regulated genes (Egr3
 
WT
 
 relative to Egr3
 
Tr
 
)
Affymetrix 
fold change
(
 
n
 
 
 
  
 
4)
Up-regulated 
in myotubes
 
 
 
fivefold (
 
n
 
 
 
  
 
4)
Up-regulated in
HSA–
 
Egr3
 
 mice
 
 
 
fivefold (
 
n
 
 
 
  
 
4)
Expression
spindles Title Gene symbol
 
a
 
NCBI accession no.
 
b
 
244.04
 
    
 
rhophilin, Rho GTPase-binding protein 2 Rphn2
 
BF228009
56.16
 
    
 
G-coupled protein receptor 50 GPR50
 
BQ032613
44.94
 
  
 
RIKEN
 
 cDNA 2810417M05 gene 2810417M05Rik
 
AK014196.1
38.87
 
plasmalemma vesicle-associated protein Plvap
 
NM_032398.1
29.07
 
 
 
synaptosomal-associated protein 25 Snap25
 
BC018249.1
27.94
 
    
 
peripherin 1 Prph1
 
NM_013639.1
27.33
 
 
 
ubiquitin protein ligase E3A Ube3a
 
BB313387
17.63
 
 
 
keratinocyte differentiation associated protein Krtdap
 
AV007306
14.37
 
 
 
suprabasin Sbsn
 
AI507307
11.91
 
  
 
hairy/enhancer-of-split related with YRPW motif 1 Hey1
 
NM_010423.1
10.62
 
cysteine dioxygenase 1, cytosolic Cdo1
 
NM_033037.1
10.26 RIKEN
 
 cDNA 1110065A22 gene 1110065A22Rik
 
BB768838
7.60
 
    
 
activity-regulated cytoskeletal-associated protein Arc NM_018790.1
7.54 F-box only 2 protein Fbxo2 BB311718
7.48 GABA-A receptor, subunit  4 GABRA4 BB430205
7.46   chloride channel 2 Clcn2 NM_009900.1
6.77 leucine-rich repeat neuronal 6A Lrrn6a BB078751
6.63 elastin microfibril interfacer 3 Elimin3 BG076147
6.61 ribosomal protein S6 kinase polypeptide 1 Rps6ka1 NM_009097.1
6.48 dermokine; epidermal secreted protein Dmkn BI452905
6.33 keratin complex 1, acidic, gene 18 Krt1-18 NM_010664.1
6.23      somatostatin receptor 2 Sstr2 NM_009217.1
5.97    neuronal d4 domain family member Neud4 AW553317
5.94    ATPase, Na
 /K
  transporting,  3 polypeptide Atp1 3 BC027114.1
5.81 IKKb, epsilon Nfkbie BB820441
5.73 brain-specific protease-4 (BSSP-4) Prss22 NM_133731.1
5.62 hypothetical protein LOC327991 LOC327991 BB346082
5.59      nerve growth factor receptor (p75) Ngfr BB151515
5.23 ESTs — BB251859
5.19 RIKEN cDNA A030009H04 gene A030009H04Rik NM_020591.1
4.99 inhibin   Inh  NM_010564.1
4.82 RIKEN cDNA 3110007G05 gene 3110007G05Rik BE992549
4.78 procollagen, type II,  1 Col2 1 NM_031163.1
4.49 serologically defined colon cancer antigen 33 Sdccag33 AV291373
4.44 ubiquitin COOH-terminal hydrolase L1 Uchl1 NM_011670.1
4.41 RIKEN cDNA 8430427H17 gene 8430427H17Rik BM120675
4.40 Mus musculus, clone IMAGE:5368459, mRNA — BF468072
4.27 neural apoptosis regulated convertase 1 Narc1 AV010795
4.25 leptin receptor Lepr BM124366
4.24 RIKEN cDNA 2210010L05 gene 2210010L05Rik BC016598.1
4.23 hairy/enhancer-of-split related with YRPW motif 2 Hey2 NM_013904.1
4.13 RIKEN hypothetical protein, 6330405H19 6330405H19Rik BB225226
4.04 carbonic anhydrase 2 Car2 NM_009801.2
3.94 GRP1-associated scaffold protein Grasp NM_019518.1
3.77 septin 4 Sept4 AW208509
3.75 RIKEN hypothetical protein, C130068N17 C130068N17Rik AW548377
3.55 neuron-specific enolase 1 Nse1 BC002154.1
3.53 thiosulfate sulfurtransferase, mitochondrial Tst BC005644.1
3.51 chemokine (C-X3-C motif) ligand 1 Cx3cl1 AF071549.1
3.49 forkhead box A3 Foxa3 AK019022.1
3.44 periaxin Prx BG072867
3.41 preproenkephalin 1 Penk1 M13227.1
3.41 chloride channel K1 Clcnk1 C76734
3.30 phospholipase C  Plc  NM_019676.1
3.21 RIKEN cDNA clone, A030009H04 A030009H04Rik AK002962.1
3.19 RIKEN cDNA clone, 1810017F10 1810017F10Rik BC019563.1
3.12 Ets transcription factor Spi-B Spi-B BM244106
3.09 RIKEN cDNA clone, B230331L10 B230331L10Rik BB357157
3.07 ESTs — BE948505
3.06 ephrin A3 Efna3 AA388313
2.99 RIKEN cDNA clone, E030041H03 E030041H03Rik BB535044
2.97 caspase recruitment domain family, member 10 Card10 NM_130859.1
2.96 elongation of very long chain fatty acids Elovl1 BB145065
2.96 amnionless Amn NM_033603.1
2.94 phenylethanolamine-N-methyltransferase Pnmt NM_008890.1
2.87 RIKEN cDNA, 2210010L05 2210010L05Rik BF225441
2.84 melanoma cell adhesion molecule Mcam NM_023061.1
83 genes were up-regulated between 2- and 244-fold by Egr3 in myotubes in all of the four comparative analyses performed from two independent microarray experiments. Some
of these genes have been verified as up-regulated by real-time PCR in Egr3-expressing myotubes, in HSA–Egr3 transgenic muscle tissue, and by in situ hyrbridization as indicated.
The gene symbol names for all gene entries coincide with the symbols used by the National Center for Biotechnology Information (NCBI) databases.
aNCBI unified gene nomenclature according to Entrez Gene.
bNCBI GenBank accession number of sequence used to generate gene feature on Affymetrix chip.GENE REGULATION AND MUSCLE SPINDLE MORPHOGENESIS • ALBERT ET AL. 261
intrafusal muscle fiber–restricted genes that are regulated by
Egr3. These results indicate that the target genes identified in
vitro may at least partially represent the Egr3-mediated gene
regulatory network involved in spindle morphogenesis.
A role for Egr3 in myotube fate 
specification and intrafusal muscle fiber 
morphogenesis
During skeletal muscle development, Ia-afferents contact a rela-
tively small number of myotubes to engage the Nrg1–ErbB2 sig-
naling that specifies whether they will become intrafusal muscle
fibers. Egr3 appears to have a role in regulating at least some tar-
get genes that are involved in spindle morphogenesis, but it is
not known what role it may have in myotube fate specification
that is mediated by Ia-afferent–Nrg1 signaling. To examine
whether Egr3 has an instructive role in myotube fate specifica-
tion, transgenic mice were generated using the human skeletal
actin (HSA) promoter to enforce Egr3 expression in all skeletal
myotubes independent of Ia-afferent–Nrg1 regulation (Fig. 4 A).
It was not possible to generate transgenic founders that could be
used to establish lines of transgenic mice because they were not
viable. To facilitate the analysis of the transgenic founders, real-
time PCR was used to examine the level of Egr3 expression
from forelimb-derived RNA in every embryo that was gener-
ated. Animals were analyzed based upon their genotype and
level of Egr3 expression by grouping them into those that did
not carry the transgene (Tg ; wild type), those that carried the
transgene but did not express transgenic Egr3 above endogenous
levels (Tg / ), those that expressed low levels of transgenic
Egr3 (Tg /L; 3–10-fold increased expression relative to Tg 
mice), and those that expressed high levels of transgenic Egr3
(Tg /H;  10-fold increased expression relative to Tg  mice;
Fig. 4 B). Late gestation embryos that expressed the transgene
(Tg /L and Tg /H) were consistently smaller than their trans-
gene negative (Tg ) or nontransgene-expressing (Tg / ) litter
mates (Fig. 4 C). E18.5 transgene-expressing mice had beating
hearts, flexion contractures of their extremities, no spontaneous
or evoked motor activity, and were not viable at birth (Fig. 4 D).
The level of Egr3 expression in particular founder mice corre-
lated with the relative number of muscle fibers that expressed
Egr3. Egr3 expression in E18.5 wild-type skeletal muscle was
restricted to developing spindles, which were relatively few in
number (Fig. 4 E, arrows), whereas Egr3 was expressed by most
of the muscle fibers in transgene-expressing mice (Fig. 4 F).
Transgene-expressing mice had poorly formed skeletal
muscles that were generally more poorly formed in Tg /H
muscles than in Tg /L muscles. As expected, muscles from
mice that did not express the transgene (Tg / ) appeared
normal. In E18.5 wild-type hindlimbs, discrete muscles were
readily identified (Fig. 5 A), whereas distinct muscles were
largely absent in transgene-expressing hindlimbs (Fig. 5 B).
Wild-type muscle fibers contained skeletal myofilaments and
subsarcolemmal nuclei that are typical of immature skeletal
myofibers (Fig. 5, C and E). Occasional spindles were identi-
fied that consisted of intrafusal muscle fibers with scant myo-
2.82 brain-specific angiogenesis inh. 1-associated protein 2 Baiap2 AF390178.1
2.82 myosin light chain, phosphorylatable, cardiac ventricles Mylpc NM_010861.1
2.82 prostaglandin I receptor (IP) Ptgir AV373771
2.80 transforming growth factor,  1 Tgfb1 NM_011577.1
2.73 ESTs similar to pentraxin I (NP-I) — AI152800
2.73 ESTs — AW046863
2.69 superoxide dismutase 3, extracellular Sod3 U38261.1
2.69 fatty acid desaturase 2 Fads2 NM_019699.1
2.65 syndecan 1 Sdc1 BI788645
2.63 semaphorin 3B Sema3b NM_009153.1
2.62 RIKEN cDNA, C030047F10 C030047F10Rik BE996518
2.59 cullin 4B Cul4b AW536452
2.56 RIKEN cDNA, 9130011B11 9130011B11Rik BG068678
2.50 RIKEN cDNA, 2900002H16 2900002H16Rik NM_021430.1
2.36 fatty acid desaturase 2 Fads2 BB430611
2.27 amyloid   (A4) precursor-like protein 1 Aplp1 AI848048
Table I. Up-regulated genes (Egr3WT relative to Egr3Tr)
Affymetrix 
fold change
(n   4)
Up-regulated 
in myotubes
 fivefold (n   4)
Up-regulated in
HSA–Egr3 mice
 fivefold (n   4)
Expression
spindles Title Gene symbol
a NCBI accession no.
b
83 genes were up-regulated between 2- and 244-fold by Egr3 in myotubes in all of the four comparative analyses performed from two independent microarray experiments. Some
of these genes have been verified as up-regulated by real-time PCR in Egr3-expressing myotubes, in HSA–Egr3 transgenic muscle tissue, and by in situ hyrbridization as indicated.
The gene symbol names for all gene entries coincide with the symbols used by the National Center for Biotechnology Information (NCBI) databases.
aNCBI unified gene nomenclature according to Entrez Gene.
bNCBI GenBank accession number of sequence used to generate gene feature on Affymetrix chip.
Table II. Down-regulated genes (Egr3WT relative to Egr3Tr)
Affymetrix
fold change
(n   4) Title Gene symbol
a
NCBI accession
no.
b
 2.94 Mus musculus n-BAK1 (Bak1) Bak1 AF402617.1
 2.75 myogenic factor 6 Myf6 NM_008657.1
 2.71 acetylcholinesterase Ache NM_009599.1
 2.16 LIM and cysteine-rich domains 1 Lmcd1 BC019124.1
 2.15 RIKEN cDNA 1110019L22 gene 1110019L22Rik AK003826.1
Five genes were identified as down-regulated between 2- and 2.9-fold. None of these
genes has been investigated further as indicated. The gene symbol names for all gene
entries coincide with the symbols used by the National Center for Biotechnology
Information (NCBI) databases.
aNCBI unified gene nomenclature according to Entrez Gene.
bNCBI GenBank accession number of sequence used to generate gene feature on
Affymetrix chip.
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fibrillary architecture and internal nuclei. Sections through
the equatorial plane of the spindles showed prominent annu-
lospiral axons (Ia-afferents) circumscribing the intrafusal
muscle fibers within rudimentary spindle capsules (Fig. 5 E,
arrowhead). In contrast, all muscle fibers from transgene-
expressing mice contained scant myofilaments with centrally lo-
cated nuclei. Although most were single multinucleated fibers
that had myofibrillary structure and nuclear features indistin-
guishable from intrafusal muscle fibers, many were aggre-
gated into clusters that were similar to intrafusal muscle fibers
within spindles (Fig. 5, D and F [arrow]). Most of the in-
trafusal-like muscle fibers were not encapsulated or inner-
vated as determined from an analysis of serially sectioned,
resin-embedded hindlimbs. Occasional normal-appearing spin-
dles were identified in muscles from transgene-expressing
mice that had the typical configuration of three to four in-
trafusal muscle fibers, which were circumscribed by annu-
lospiral sensory axons and rudimentary capsules (Fig. 5 F,
arrowhead). Thus, Egr3 expression in skeletal myotubes inde-
pendent of other Ia-afferent signaling has the remarkable ca-
pacity to transform them into muscle fibers that are structurally
similar to intrafusal muscle fibers, presumably orchestrated
by the network of genes it regulates.
Figure 2. Pea3 expression in wild-type and Egr3-deficient muscle is a
marker of Ia-afferent–contacted myotubes in vivo. (A) At E16.5, shortly
after Ia-afferent contact is made with myotubes, Pea3 is expressed in both
wild-type and Egr3-deficient myotubes. In Egr3-deficient muscles, the
number of myotubes that express Pea3 is reduced by 66% in E16.5 em-
bryos, and (B) in E18.5 embryos, they are reduced by 86%. Ia-afferents
are known to initially contact myotubes in Egr3-deficient mice and then
withdraw during development, which is consistent with the progressive
decrease in Pea3-expressing myotubes that are identified in Egr3-deficient
muscles. Thus, Pea3 is not regulated by Egr3 in myotubes, and it is a
marker for Ia-afferent contact. These results make it possible to use Pea3 to
localize Ia-afferent–contacted myotubes and study potential Egr3 target
gene expression within them (n   3 animals for each genotype; mean and
standard deviation shown). Insets are high power magnifications of labeled
spindles (arrows). Bars: 50  m; (inset) 10  m. Figure 3. Egr3 regulates specific target genes in developing spindles.
Affymetrix microarray analysis demonstrated many potential target genes
that are regulated by Egr3 in myotubes. Egr3 was necessary for the ex-
pression of (A) NGFR (p75), (B) SSTr2, and (C) Prph1 in muscle spindles.
The muscle expression of all of these genes was restricted to the developing
spindles (arrows), similar to the expression pattern of Egr3, whereas their
expression was abrogated in Pea3-expressing (Ia-afferent contacted),
Egr3-deficient myotubes. Bars: 50  m; (inset) 10  m.GENE REGULATION AND MUSCLE SPINDLE MORPHOGENESIS • ALBERT ET AL. 263
Intrafusal-like muscle fibers in HSA–Egr3 
transgenic muscle are not innervated
Intrafusal-like muscle fibers in Egr3 transgene-expressing mus-
cles do not have fusiform capsules, which may derive from ter-
minal Schwann cells of innervating axons. To examine whether
the transformed muscle fibers were innervated by either fusi-
motor or proprioceptive axons, parvalbumin (Pv) immunohis-
tochemistry was used as a selective marker for proprioceptive
neurons and Ia-afferents (Tourtellotte and Milbrandt, 1998),
and ATP1 3 immunohistochemistry was used as a marker for
both Ia-afferent and fusimotor axons in skeletal muscles (Do-
bretsov et al., 2003). There was no quantitative difference in
the number of proprioceptive neurons in the Tg  or Tg /H
fifth lumbar dorsal root ganglion (DRG; Fig. 6 A), and there
was no qualitative difference in the number of Pv  neurons in
any first through fourth cervical or first through fifth lumbar
DRG that were examined, suggesting that the number of inner-
vated and structurally normal spindles (Fig. 5 F, arrowhead)
was normal in Tg /H mice. However, whereas robust Pv 
Ia-afferent axons terminated on spindles in Tg  mice (and oc-
casional normal-appearing spindles in Tg /H mice), the in-
trafusal-like muscle fibers from Tg /H mice showed no evi-
dence of Ia-afferent innervation (Fig. 6 B). Similarly, the
Figure 4. Enforced Egr3 expression in all skeletal myotubes leads to
muscle defects and perinatal mortality. (A) The human skeletal actin (HSA)
promoter was used to express Egr3 in all skeletal myotubes independent
of normal Ia-afferent–mediated regulation. PCR was used to genotype the
mice using the primers indicated (s and as). (B) Perinatal founder mice
were not viable, making it necessary to characterize all of the individual
embryos generated from the pronuclear injections. Using real-time PCR to
examine the expression of Egr3 in muscle, a total of 58 embryos were
studied by separating them into four groups: (1) those that did not carry
the transgene (Tg ); (2) those that carried the transgene but did not ex-
press it (Tg / ); (3) those that carried the transgene and expressed it at
low levels (Tg /L; 3–10-fold increase in Egr3 expression relative to Tg 
muscles); and (4) those that carried the transgene and expressed it at high
levels (Tg /H;  10-fold increase in Egr3 expression relative to Tg 
muscles; n   8–20 embryos per group; mean and standard deviation
shown). (C) The transgene-expressing mice were consistently smaller than
either their Tg  or Tg /  litter mates (n   8–20 embryos per group;
mean and standard deviation shown). (D) The late gestational (E18.5)
Tg /L and Tg /H embryos had beating hearts, flexion contractions, and
exhibited no spontaneous or evoked motor activity. Bars, 5 mm. (E) In situ
hybridization demonstrated normal Egr3 expression in developing spin-
dles in both Tg  and Tg /  muscles (arrows). (F) In contrast, Tg  mice
expressed the transgene in most muscle fibers, many of which were aggre-
gated into fibers with numerous internal nuclei. Bars, 0.5 mm.
Figure 5. Skeletal myotubes are transformed into muscle fibers that are
structurally similar to intrafusal muscle fibers in HSA–Egr3 transgenic
mice. E18.5 (A, C, and E) wild-type and (B, D, and F) Tg /H transgenic
hindlimbs. (A) In wild-type embryos, skeletal muscles were discretely
formed (lower hindlimb shown), whereas (B) in HSA–Egr3 transgene-
expressing embryos, the individual muscles were poorly distinguished.
Boxed areas in A and B are shown in C and D at higher magnifications.
(C and E) Discrete wild-type muscles contained normal muscle fibers that
were distended by skeletal myofilaments and contained subsarcolemmal
nuclei. (C) Occasional normal spindles were noted (arrowhead). (E) They
contained three to four intrafusal muscle fibers with scant myofibrillary
structure and internal nuclei, which were surrounded by axons (Ia-afferents)
and rudimentary capsules (arrowhead). (D) Muscle fibers from transgene-
expressing mice had scant myofibrillary structure and internal nuclei similar
to those of intrafusal muscle fibers. (F) Many of the fibers were aggregated
into spindle-like structures that lacked capsules or obvious innervation
(arrow). Scattered, normal-appearing spindles were noted to have capsules
and innervation (arrowhead). Bars: (A and B) 500  m; (C and D) 20  m;
(E and F) 100  m.JCB • VOLUME 169 • NUMBER 2 • 2005 264
transformed muscle fibers were not able to sustain motor inner-
vation as indicated by the near complete loss of motor neurons
in the spinal cord and the absent ventral roots in Tg /H mice
(Fig. 6 C). In the periphery, ATP1 3 identified fusimotor and
Ia-afferent axons that terminated selectively on normal spin-
dles, whereas there was no evidence of such innervation in the
transformed muscle fibers in Tg /H muscles (Fig. 6 D).
Pea3 is expressed in myotubes that have been contacted
by Ia-afferents, but in Tg /H muscle there was no change in
the number of Pea3-expressing myotubes or the expression
level of Pea3 in transgene-expressing muscle (Fig. 6 E). These
results are consistent with our findings that Pea3 is not regu-
lated by Egr3 (Fig. 2), that some morphologically intact spin-
dles are innervated in transgene-expressing muscles (Fig. 5 F,
arrowhead), and that the transformed muscle fibers are not in-
nervated by Ia-afferents that would otherwise be expected to
induce high levels of Pea3 expression. Thus, myotubes that ex-
press Egr3 in the absence of other Ia-afferent–derived signaling
are morphologically similar to intrafusal muscle fibers, but
they are devoid of intact fusiform capsules and are incapable of
attracting and/or sustaining their innervation.
Muscle fibers from HSA–Egr3 transgenic 
mice express genes similar to those of 
intrafusal muscle fibers
Enforced expression of Egr3 in skeletal myotubes is sufficient
to transform them into muscle fibers that structurally resemble
intrafusal muscle fibers. To examine whether they also express
genes that are characteristic of intrafusal muscle fibers, several
well-established intrafusal muscle fiber markers and some
newly identified markers were examined in HSA–Egr3 trans-
genic muscles. In wild-type muscle, Sd-MyHC is expressed by
the Ia-afferent contact of myotubes as one of the earliest mark-
ers of intrafusal muscle fiber formation. Sd-MyHC is not
expressed in Ia-afferent–contacted, Egr3-deficient myotubes,
suggesting that they are impaired in their capacity to differenti-
ate into intrafusal muscle fibers (Tourtellotte and Milbrandt,
1998; Tourtellotte et al., 2001). Sd-MyHC was localized to in-
trafusal muscle fibers in developing spindles in wild-type
(Tg ) muscle as previously reported, whereas it was expressed
by 15-fold more fibers in Tg /H muscles, indicating that some
myotubes had acquired at least one phenotype of intrafusal
muscle fibers (Fig. 7 A). The neurotrophins NT-3 and glial-
derived neurotrophic factor (GDNF) are preferentially expressed
by intrafusal muscle fibers in E18.5 muscle and are required for
their sensory and fusimotor innervation, respectively (Ernfors
et al., 1994; Whitehead et al., 2005). Relative to Tg  muscles,
neither GDNF nor NT-3 was up-regulated in Tg /  muscles,
but both were up-regulated 4- and 5.2-fold, respectively, in
Tg /H muscles (Fig. 7 B). The newly identified Egr3 target
genes NGFR (p75), SSTr2, and Prph1 were not up-regulated in
Tg /  muscles relative to Tg  muscles, whereas they were
all up-regulated in Tg /H muscle 6.4-, 6.7-, and 4-fold, re-
spectively (Fig. 7 C). Finally, several other genes identified as
potential Egr3 target genes in primary myotubes (Fig. 1 D)
were also up-regulated in Tg /H muscles. ATP1 3, harry
Figure 6. Intrafusal-like muscle fibers are not
innervated in HSA–Egr3 transgene-expressing
mice. (A) A subset of proprioceptive neurons
in the dorsal root ganglia (DRG) give rise to
Ia-afferents that express parvalbumin (Pv).
There was no difference in the number of Pv 
neurons in DRG between Tg  and Tg /H
mice (fifth lumbar DRG shown), which is consis-
tent with normal innervation of some spindles
in Tg /H muscles (n    4 for each geno-
type; mean and standard deviation shown).
(B) However, although Pv  Ia-afferents were
robustly labeled in normal spindles in Tg 
(arrowhead) and Tg /H mice (not depicted),
there was no evidence of Pv  axon innerva-
tion in any of the transformed myotubes in
Tg /H muscles. (C) Muscles in Tg /H mice
were not capable of sustaining any motor in-
nervation. Motor neurons (mn) present in Tg 
spinal cords (lumbar cord shown) were en-
tirely absent in Tg /H mice, leaving only
spinal  interneurons in their place. Complete
motor neuron loss was corroborated by the
absence of ventral roots (vr), which carry motor
axons into the periphery. (D) Spindles in Tg 
muscles received both Ia-afferent and fusimo-
tor innervation, which was robustly labeled by
ATP1 3 immunohistochemistry, whereas no
ATP1 3-labeled axons innervated the trans-
formed myotubes in Tg /H muscles. Arrow-
heads indicate the spindles innervated by
ATP 3-containing axons. (E) Consistent with
the observation that Pv  neurons are not al-
tered in Tg /H mice, Ia-afferent–contacted, Pea3-expressing myotubes were observed in Tg /H muscles, and Pea3 expression was not significantly dif-
ferent from wild-type (Tg ) or nontransgene-expressing (Tg / ) muscles (n   4 for each condition; mean and standard deviation shown). Inset shows a
magnified image of the Pea3-expressing spindle (arrow). Bars: (A, C, and E) 50  m; (B and D) 20  m; (inset) 10  m.GENE REGULATION AND MUSCLE SPINDLE MORPHOGENESIS • ALBERT ET AL. 265
enhance of split 1 (Hey1), and 2810417MoRik were not up-reg-
ulated in Tg /  muscles relative to Tg  muscles, whereas
they were up-regulated 11.2-, 10.3-, and 7.3-fold, respectively.
Together, these data demonstrate that enforced Egr3 expression
in skeletal myotubes leads to their transformation into muscle
fibers that are structurally similar to intrafusal muscle fibers
and that express many genes characteristic of them.
Discussion
During skeletal muscle development, Ia-afferents specify the
fate of myotubes by engaging novel gene transcription that
transforms them into biochemically and functionally distinct
intrafusal muscle fibers. Recent studies have refined our under-
standing of this classic nerve–muscle induction process by
demonstrating that Nrg1 produced by Ia-afferents and signal-
ing through the Nrg1 tyrosine kinase receptor ErbB2 in con-
tacted myotubes is essential to engage the spindle morphogene-
sis program in vivo (Andrechek et al., 2002; Hippenmeyer et
al., 2002; Leu et al., 2003) and in vitro (Jacobson et al., 2004).
Moreover, Nrg1 signaling from Ia-afferents is necessary to in-
duce several transcription factors (Egr3, Pea3, ER81, and
ERM), which represent at least some proximal mediators of the
gene regulatory networks that are engaged by Ia-afferent con-
tact with myotubes. We focused on the role of Egr3 in mediat-
ing particular aspects of Ia-afferent (Nrg1–ErbB2) signal trans-
duction because our earlier work indicated that Egr3 is required
for normal spindle morphogenesis (Tourtellotte and Milbrandt,
1998). Its expression is restricted to Ia-afferent–contacted myo-
tubes, and Egr3-deficient, Ia-afferent–contacted myotubes do
not acquire characteristic structural features or phenotypic
markers of intrafusal muscle fibers (Tourtellotte et al., 2001;
Chen et al., 2002).
Egr3 gene regulation in Ia-afferent–
contacted myotubes
Egr3 regulates a relatively large network of genes within myo-
tubes, and although not all of the genes identified were charac-
terized further in this study, some of them were regulated by
Egr3 in developing intrafusal muscle fibers. We found that
NGFR (p75), SSTr2, and Prph1 are regulated by Egr3 in in-
trafusal muscle fibers. Of the 83 genes identified by expression
analysis in myotubes, we verified that 15/15 genes tested were
up-regulated, suggesting that the list of Egr3 target genes has a
high degree of specificity. Moreover, the Egr3-mediated gene
regulatory network is evidently complex because the target
genes have tremendous functional diversity, including pro-
cesses such as transcriptional regulation, intracellular signal
transduction, protein processing, and cytoskeletal organization.
Interestingly, however, not all genes that were up-regulated by
Egr3 in myotubes in vitro were Egr3 targets in the developing
intrafusal muscle fibers in vivo because neither GPR50, Rphn2,
nor Arc was expressed by them. Thus, enforced expression of
Egr3 in myotubes leads to target gene expression that is not nec-
essarily restricted to the myotube–cellular context. In support of
this concept, studies in progress indicate that Arc is directly reg-
ulated by Egr3 in neurons, despite the fact that it is not ex-
pressed by intrafusal muscle fibers where Egr3 is expressed at
high levels (unpublished data). These results indicate that the
cellular context appears to be important in providing a permis-
sive environment for expression of a particular repertoire of
Egr3 target genes that are relevant to intrafusal muscle fiber
morphogenesis. Whether the target genes identified are directly
regulated by Egr3 or whether they are expressed by the activa-
tion of downstream mediators of Egr3 is currently not known.
Moreover, it is not known whether any of these newly identified
Egr3 target genes are essential for spindle morphogenesis.
Figure 7. Muscle fibers in HSA–Egr3 trans-
genic mice express genes that are characteristic
of intrafusal muscle fibers. (A) Slow develop-
mental myosin heavy chain (Sd-MyHC), a
well-established marker for intrafusal muscle
fibers, was expressed selectively by the rela-
tively few intrafusal muscle fibers present in
wild-type muscles (arrows), whereas it was
markedly up-regulated by muscle fibers in
Tg /H mice. (bar graph) The number of Sd-
MyHC–expressing myotubes was significantly
increased in Tg  relative to Tg  mice when
the number of myotubes/section were counted
in lower hindlimb muscles. Bars: 50  m; (inset)
25  m. (B) Similarly, expression of the neu-
rotrophins NT-3 and GDNF, both of which are
expressed in muscle primarily by intrafusal
muscle fibers in E18.5 wild-type mice, were
up-regulated in Tg /H muscles but not in non-
transgene-expressing muscles (Tg / ) rela-
tive to wild type (Tg ). (C) The expression of
NGFR (p75), SSTr2, and Prph1, three newly
identified target genes that are regulated by
Egr3 in spindles, were also markedly up-regu-
lated, as were (D) several other genes
(ATP1 3, Hey1, and 2810417MoRik) that
were examined from the Egr3 target gene mi-
croarray analysis results (mean and standard
deviation shown; n    4 embryos for each
genotype; *, P   0.05; **, P   0.01).JCB • VOLUME 169 • NUMBER 2 • 2005 266
An analysis of additional Egr3 target genes by in situ hybridiza-
tion will be necessary to further define the Nrg1–ErbB2–Egr3 reg-
ulatory axis that mediates intrafusal muscle fiber morphogenesis.
Ia-afferents have a broad regulatory influence over spindle
morphogenesis, and Egr3 regulation is apparently only part of
the complex morphogenetic signaling pathway. Many of the
genes that are up-regulated during the early aspects of muscle
spindle morphogenesis, such as Egr3, ERM, ER81, and Pea3, are
independently regulated (Hippenmeyer et al., 2002). Thus, mul-
tiple parallel regulatory networks likely exist, and they may have
distinct roles during spindle morphogenesis. For example, the
role of ERM during spindle morphogenesis has not been deter-
mined because ERM-deficient mice die before spindle morpho-
genesis is initiated, but its function in muscles is not likely to be
restricted to spindle morphogenesis because it is expressed by in-
trafusal and nonintrafusal muscle fibers. Pea3, which neither reg-
ulates Egr3 nor is regulated by Egr3, is not necessary for spindle
morphogenesis despite the fact that in muscles its expression is
restricted to intrafusal muscle fibers (Livet et al., 2002). Pea3,
which is also expressed in motor neurons and is regulated by
GDNF, has a role in patterning motor innervation rather than in
spindle morphogenesis itself (Haase et al., 2002; Livet et al.,
2002). Similarly, ER81 has a role in sensory patterning, which
may explain the partial disruption of spindle morphogenesis in
ER81-deficient mice secondary to altered sensory innervation on
which spindle morphogenesis depends (Kucera et al., 2002). In
contrast, Egr3 appears to have a selective role in mediating some
aspects of Ia-afferent signaling that are related to intrafusal mus-
cle fiber differentiation because its restricted expression to spin-
dles is required for their normal morphogenesis. Thus, Egr3-
mediated gene regulation appears to be necessary for myotubes
to acquire a normal intrafusal muscle fiber phenotype.
Myotube fate specification mediated by 
Egr3 target gene regulation
Although Egr3 expression is necessary for normal intrafusal
muscle fiber morphogenesis, it also appears to be sufficient to
drive some aspects of intrafusal muscle fiber differentiation
from otherwise undifferentiated skeletal myotubes. Skeletal
myotubes were transformed into muscle fibers that had struc-
tural and molecular similarities to intrafusal muscle fibers
when Egr3 expression was enforced independently of Ia-affer-
ent signaling. Moreover, several established intrafusal muscle
fiber markers, including Sd-MyHC, NT-3, and GDNF were up-
regulated in HSA–Egr3 transgene-expressing muscles. Simi-
larly, three new Egr3 target genes that were selectively ex-
pressed by intrafusal muscle fibers (NGFR [p75], SSTr2, and
Prph1) and three additional Egr3 target genes (ATP1 3, Hey1,
and 2810417MoRik) were all up-regulated in transgene-express-
ing muscles. However, the transformed muscle fibers did not
acquire the motor or sensory innervation that is characteristic
of normal intrafusal muscle fibers, suggesting that Egr3 has a
role that is distinct from other Ia-afferent–mediated pathways
that may be required to establish and/or maintain these interac-
tions. Moreover, the transformed myotubes did not acquire
fusiform capsules that may normally be derived from terminal
Schwann cells of the innervating sensory axons. Finally, somatic
motor neurons were almost completely absent in HSA–Egr3
transgenic mice, indicating that the transformed muscle fibers
were not capable of sustaining skeletomotor innervation that
would have been present had they not expressed Egr3 and dif-
ferentiated into intrafusal muscle fibers. It will be necessary to
conditionally express Egr3 in skeletal myotubes in order to
study the fate of motor and sensory innervation during devel-
opment because the transgenic founders died and could be gen-
erated only in small numbers.
Sensory control over the morphogenesis of many mecha-
noreceptors is recognized as a common theme in their ontog-
eny. A detailed understanding of the gene regulatory mecha-
nisms that are governed by sensory axon innervation of muscle
spindles may be applicable to mechanisms used during the on-
togeny of other sensory mechanoreceptors. These studies de-
fine a set of Egr3-regulated target genes, some of which appear
to be relevant to intrafusal muscle fiber morphogenesis. Egr3 is
regulated by Nrg1–ErbB2 signaling, and it appears to mediate
gene expression that is necessary and sufficient to specify the
fate of Ia-afferent–contacted myotubes to become intrafusal
muscle fibers and to mediate their morphogenesis.
Materials and methods
Animals and preparation of tissues
Egr3-deficient mice were mated on a C57BL/6/129SvJ background and
were generated and genotyped as previously described (Tourtellotte and
Milbrandt, 1998; Whitehead et al., 2005).
The HSA–Egr3 transgenic mice were generated by using the previ-
ously characterized HSA promoter to express Egr3 in skeletal myotubes
(Muscat et al., 1992). The transgenic construct was derived from pBSX-
HSAvpA (Crawford et al., 2000; provided by J. Chamberlain, University
of Washington, Seattle, WA) by cloning a full-length, HA-tagged Egr3
cDNA into the NotI site of pBSX-HSAvpA. The construct was injected into
B6SJL embryo pronuclei and transplanted into recipient females using
standard procedures (provided by L. Doglio and R. Alvarez, Northwestern
University, Chicago, IL). The transgene-expressing founder mice were not
postnatally viable, and, therefore, recipient females were killed to analyze
founder embryos at various gestational ages. Each embryo was geno-
typed using primers 5 -AAACTCGCCGAGAAGCTGCCGGTG-3  (sense)
and 5 -TGTGCATCCATCGCTAGCTCGCTC-3  (antisense) to amplify a
230-bp fragment of the endogenous Egr3 genomic locus. A third primer,
5 -TCAGGGAGACGTGGAGGCCATGTA-3 , was used to amplify a 413-
bp fragment of the Egr3 cDNA transgene (nonintron containing) when
paired with the sense probe in a multiplex PCR reaction.
The day of vaginal plug for all of the mice was considered as E0.5.
The embryos were isolated by cesarean section, were rapidly decapitated,
were fixed at 4 C in 100 mM phosphate-buffered 4% PFA, and were ei-
ther cryoprotected for 24 h in 30% phosphate-buffered sucrose and frozen
or were directly embedded in paraffin. Serial paraffin sections (8  m) or
frozen sections (15  m) were generated. Some tissues were embedded in
resin, in which case the fixative was substituted for 2.4% glutaraldehyde
and 1% PFA. The tissues were dehydrated in increasing concentrations of
ethanol that was infiltrated with Embed 812 resin (Electron Microscopy Sci-
ences) and heat cured at 60 C overnight. Resin sections were cut at 1  m
and were counterstained with toluidine blue (Sigma-Aldrich).
Myoblast isolation and myotube culture
Hindlimb skeletal muscle tissues were isolated from wild-type, postnatal
(3–5) mice. Myoblasts were isolated by enzymatically dissociating (dis-
pase, grade II, 2.4 U/ml; Boehringer), and the muscle tissues were tritu-
rated according to previously published procedures (Rando and Blau,
1994). Myoblasts were purified by multiple rounds of preplating on col-
lagen-coated tissue culture plates (0.01% type I; Sigma-Aldrich) and ex-
panded in growth medium (Ham’s F10; Mediatech), 20% FBS, and 2.5
ng/ml basic FGF (Promega). Purified primary myoblasts were plated onto
collagen-coated plates and were differentiated into multinucleated myotubes
for 10 d using differentiation medium (Ham’s F10 and 5% horse serum).GENE REGULATION AND MUSCLE SPINDLE MORPHOGENESIS • ALBERT ET AL. 267
Recombinant adenovirus preparation, characterization, 
and myotube infection
Recombinant adenoviruses were generated using homologous recombina-
tion in Escherichia coli as previously described (He et al., 1998). To gen-
erate an adenovirus that expressed transcriptionally active Egr3, the full-
length rat Egr3 cDNA (GenBank/EMBL/DDBJ accession no. NP058782,
aa 1–387) was cloned into the BglII site of pAdTrackCMV. Similarly, a
transcriptionally inactive, COOH-terminal truncation of Egr3 that lacked
the entire three zinc finger DNA-binding and COOH-terminal domains
(GenBank NP058782, aa 1–245) was cloned into the BglII site of
pAdTrackCMV. Each recombinant pAdTrack shuttle vector, including
pAdTrackCMV without a cDNA insert, was recombined by homologous
recombination into the adenoviral genomic plasmid (pAdEasy) in BJ5183
E. coli to generate a recombinant, replication-deficient adenoviral genome
plasmid. The three replication-deficient viruses (EGFP, Egr3WT, and Egr3Tr)
were packaged and amplified in transfected HEK-293 cells, purified, con-
centrated on cesium chloride gradients, and titered using EGFP fluores-
cence and TCID50.
NIH-3T3 fibroblasts were infected with the recombinant adenovi-
ruses at a multiplicity of infection (MOI) of 10–20 to obtain  70–80% in-
fection efficiency. Total cell lysates were obtained 24 h after infection, and
a Western blot using an NH2-terminal Egr3, rabbit polyclonal antibody
(O’Donovan et al., 1998) demonstrated a high expression of full-length
and truncated Egr3 protein as expected. Myoblasts were cotransfected
with an early growth response element (ERE) containing a firefly luciferase
reporter plasmid (Swirnoff and Milbrandt, 1995) and a Renilla luciferase
reporter plasmid (pRL-TK; Promega) for transfection efficiency control. 16 h
after plasmid cotransfection, the cells were infected with either control
EGFP, Egr3WT, or Egr3Tr adenoviruses at an MOI of 10 to obtain 80–90%
infection efficiency. 8 h after infection, a dual-reporter luciferase assay was
performed to quantify ERE activation by the virally produced proteins ac-
cording to the manufacturer’s specifications (Promega).
Primary myotubes that differentiated for 10 d in vitro were infected
with either Egr3WT or Egr3Tr adenovirus at an MOI of 100 to obtain 100%
infection efficiency. Although myotubes were relatively resistant to infec-
tion and required a relatively high MOI for optimal infection, no evidence
of toxicity was noted 24 h after infection at the time that total RNA was ex-
tracted from the infected myotubes.
Gene expression profiling
5  g of total RNA was converted to cDNA using the superscript reverse
transcriptase (Invitrogen) and the T7-Oligo (dT) promoter primer kit (Af-
fymetrix, Inc.). The cDNA was purified using the GeneChip sample
cleanup module (Affymetrix, Inc.) and was used for the in vitro synthesis of
biotin-labeled cRNA using the GeneChip expression 3 -amplification re-
agents for IVT labeling (Affymetrix, Inc.) at 37 C for 16 h. cRNA was frag-
mented into 35–200–bp fragments using a magnesium acetate buffer (Af-
fymetrix, Inc.). 10  g of labeled cRNA were hybridized to GeneChip
mouse expression arrays (430A and 430B; Affymetrix, Inc.) for 16 h at
45 C. The GeneChips were washed and stained according to the manu-
facturer’s recommendations (Affymetrix, Inc.) using the GeneChips fluidics
station (model 450; Affymetrix, Inc.). This procedure included washing the
chips with phycoerythrin-streptavidin, performing signal amplification by a
second staining with biotinalyted antistreptavidin, and performing a third
staining with phycoerythrin-streptavidin. Each chip was scanned using the
GeneChips scanner (model 3000; Affymetrix, Inc.). Signal intensity and
detection calls were generated using the GeneChip operating software (Af-
fymetrix, Inc.). The absolute intensity values of each chip were scaled to the
same target intensity value of 150 in order to normalize the data for inter-
array comparisons. Four chip comparisons were generated using the sam-
ples from transcriptionally inactive Egr3 (Egr3Tr)-infected myotubes as the
baseline. A list of up-regulated and down-regulated genes with a greater
than twofold change was generated using an iterative comparison analysis
(Chen et al., 2000). This method has been shown by the National Institutes
of Health‘s (NIH) Microarray Consortium to increase specificity ( 80%
true positive rates) in the resultant gene list. The annotated MAGE-ML and
image fields are available at http://arrayconsortium.tgen.org.
Real-time PCR
Total RNA was isolated from the primary myotubes or mouse muscle tissue
using TRIzol (Invitrogen), and 0.5–1.0  g was reverse transcribed using
random octomer priming and powerscript reverse transcriptase according
to the manufacturer’s specifications (BD Biosciences). Real-time PCR was
performed on a sequence detector (model SDS5700; Applied Biosystems)
using Syber green fluorescence chemistry (Molecular Probes). Non–intron-
spanning primers that amplified the coding sequence were designed for
each target gene. For each primer pair, melt curves were generated to iden-
tify the optimal temperature to quantify the total fluorescence after each am-
plification cycle so that only the gene-specific amplicon fluorescence was
measured during the PCR reaction. For each primer pair, serial dilutions of
mouse genomic DNA were used to generate a standard curve, to character-
ize their linear dynamic range, and to provide relative DNA concentrations
that correlated with gene expression at particular threshold cycle numbers
in the linear range of amplification. For each cDNA sample, the relative
level of the target gene and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) expression was interpolated from the gene-specific standard
curves. The expression of each target gene was normalized to the level of
GAPDH expression, and the normalized expression values were again nor-
malized to a reference condition, such as gene expression in nontransgenic
muscle or Egr3Tr-infected myotubes, to assess fold change in expression that
is relative to that condition.
Non–intron-spanning primer sequences were used for real-time PCR
analysis. They amplified the following: Egr3 (GenBank NM_018781.1, nt
163–563),  GAPDH (GenBank NM_001001303, nt 210–635), NGFR/
p75 (GenBank BC038365, nt 1123–1369), SSTr2 (GenBank
NM_009217, nt 603–859), Prph1 (GenBank NM_013639, nt 109–616),
ATP1 3 (GenBank NM_144921, nt 3074–3293), Hey1 (GenBank
NM_010423, nt 669–670), 2810417MoRik (GenBank NM_026516, nt
910–1209),  Sbsn (GenBank NM_172205, nt 36–333), Arc (GenBank
NM_018790, nt 1175–1483), GPR50 (GenBank AF065145, nt 256–
567),  Rhpn2 (GenBank NM_011872, nt 1821–2077), KLK7 (GenBank
NM_011872, nt 94–396), Krtdap (GenBank AB011028, nt 8–297), Ntf3/
NT-3 (GenBank NM_008742, nt 233–633), GDNF (GenBank D88351, nt
2552–2769),  SNAP25 (GenBank NM_011428, nt 191–498), Ube3a
(GenBank NM_173010, nt 964–1264), Clcn2 (GenBank NM_009900, nt
2710–3009), and Neud4 (GenBank NM_013874, nt 1327–1634).
In situ hybridization and immunohistochemistry
In situ hybridization was performed using digoxygenin-labeled riboprobes
and previously published standard protocols (Darby, 2000). In situ hybrid-
ization probes were generated to label coding regions from the published
mRNA sequences. The PCR-generated amplicons were polished (End-it;
Epicentre), were subcloned into the EcoRV site of Bluescript (Stratagene),
and were sequence verified. Sense and antisense riboprobes were synthe-
sized using in vitro transcription and digoxygenin-labeled dUTP. In all
cases, the sense probe was used on parallel tissue sections as a control for
nonspecific labeling, and antisense probes were used to examine gene-
specific expression.
The probes used for in situ hybridization spanned the following
coding sequences: Egr3 (GenBank NM018781, nt 890–1389), Pea3
(GenBank NM_008815, nt 533–1082), GPR50 (GenBank, AF065145,
nt 157–656), Rhpn2 (GenBank NM_027897, nt 1381–1890), Arc (Gen-
Bank NM_018790, 577–1082), NGFR (p75) (GenBank BC038365, nt
253–767),  SSTr2 (GenBank NM_009217, nt 685–1185), and Prph1
(GenBank NM_013639, nt 109–616). Wild-type muscle spindles were
identified by their characteristic morphological appearance (spindle cap-
sules surrounding muscle fibers with internal nuclei). In Egr3-deficient
mice, prospective “spindles” were identified by Pea3 expression, which
marks Ia-afferent–contacted myotubes and intrafusal muscle fibers.
Immunoperoxidase histochemistry was performed using specific rab-
bit polyclonal antibodies that cross-reacted with the COOH-terminal region
of Egr3 (sc-190; Santa Cruz Biotechnology, Inc.), the NH2-terminal region
of Egr3 (O’Donovan et al., 1998; provided by J. Baraban, John Hopkins
University, Baltimore, MD), Pv (R301; provided by K. Baimbridge, Univer-
sity of British Columbia, Canada), ATP1 3 (Upstate Biotechnology), and
Sd-MyHC (S46; provided by D. Fischman, Cornell University, New York,
NY). A biotinylated, antirabbit secondary antibody (Jackson ImmunoRe-
search Laboratories) and avidin–biotin complex histochemistry using diami-
nobenzidine as a chromagen was performed according to the manufac-
turer’s specifications (Vector Laboratories). In some cases, an antirabbit,
Cy3-conjugated secondary antibody was substituted (Jackson ImmunoRe-
search Laboratories). All photographs were acquired with a digital camera
(model RT-Slider; Spot) attached to a microscope (model E600; Nikon),
and the images were processed using Adobe Photoshop software.
Neuron counts
Stereological quantification of the total number of Pv  neurons within the
fifth lumbar DRG (n   4 per genotype) was performed using the optical
dissector method (StereoInvestigator, Microbrightfield). Every fourth sec-
tion through the fifth lumbar DRG was analyzed. Contours containing a
single DRG were optically sectioned using a 100  objective (NA 1.4)
and an oil substage condenser. The sampling sites were 175   100  m,JCB • VOLUME 169 • NUMBER 2 • 2005 268
and the counting frame boundaries were 80   60   6  m in height.
Only immunopositive neurons with sharply focused nuclei (containing at
least one nucleolus) within the optical dissector counting frame boundaries
were tallied. The total number of Pv  neurons per DRG was estimated by
the StereoInvestigator software.
Statistical measures
The Kolmogorov-Smirnov test was used to detect departures of the data
from normality. F-tests were used to check for equal variances, and, in the
case of unequal variances, the nonparametric Mann-Whitney U test was
used. When variances were equal, the t test was used. The acceptance of
significance was set to P   0.05.
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